NEW YORK – Hitachi said on Wednesday that it is partnering with ThinkCyte to develop an artificial intelligence-driven cell analysis and sorting system.
The firms plan to collaborate with pharmaceutical companies and research institutes working in the field of regenerative medicine and cell therapy to expedite commercialization of the system.